TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/04 09:26 | 9/15/04 | MATK | Martek Biosciences Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flatt James H | MD | O | SVP Rese | M.d | 559 | 27.97 | 0 | 20 | 0 | D | |||||||||||||||
9/17/04 09:26 | 9/15/04 | MATK | Martek Biosciences Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flatt James H | MD | O | SVP Rese | S.d | -1,101 | 55.04 | 0 | -20 | -100 | 0 | D | ||||||||||||||
9/15/03 19:46 | 9/11/03 | MATK | Martek Biosciences Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flatt James H | MD | O | SVP Rese | M | 50 | 11.84 | 0 | 4 | 127 | 8 | D | ||||||||||||||
9/15/03 19:46 | 9/11/03 | MATK | Martek Biosciences Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flatt James H | MD | O | SVP Rese | S.m | -216 | 51.18 | 0 | -4 | -36 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |